Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Women with effluvium have higher levels of certain urinary steroids, possibly due to stress and increased adrenal activity.

BMP signaling controls hair follicle size and cell growth by affecting cell cycle genes.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

PCOS is a common hormonal disorder in women that can be managed with lifestyle changes and various medications.

Epidermal Wnt/β-catenin signaling controls fat cell formation and hair growth.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Modified laparoscopic sleeve gastrectomy effectively controls diabetes and treats obesity with minimal complications.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Genes and hormones cause hair loss, with four genes contributing equally.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

Premature graying of hair is linked to vitamin D and B12 deficiencies, thyroid issues, iron imbalance, stress, and lifestyle habits, and affects quality of life.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Men with testicular cancer were less likely to experience baldness and severe acne.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Women with PCOS tend to be less optimistic than those without it.

A gene network led by RSL4 is crucial for early root hair growth in response to cold in Arabidopsis thaliana.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.